These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36072981)

  • 1. Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development.
    Liao W; Shi Z; Tang H; Wu T; Zhang C; He Y; Zou R; Wang L
    J Oncol; 2022; 2022():6851026. PubMed ID: 36072981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development.
    Lu TL; Li CL; Gong YQ; Hou FT; Chen CW
    World J Gastrointest Oncol; 2023 Oct; 15(10):1717-1738. PubMed ID: 37969406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of hepatocellular carcinoma mRNA vaccines based on potential tumor targets and immunophenotypes.
    Wang HK; Xu XH; Wang SM; Zhang HY
    Transl Cancer Res; 2024 Jan; 13(1):173-190. PubMed ID: 38410201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.
    Huang X; Zhang G; Tang T; Liang T
    Mol Cancer; 2021 Mar; 20(1):44. PubMed ID: 33648511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.
    Zhong H; Liu S; Cao F; Zhao Y; Zhou J; Tang F; Peng Z; Li Y; Xu S; Wang C; Yang G; Li ZQ
    Front Immunol; 2021; 12():709986. PubMed ID: 34512630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine.
    Hu J; Mo Z
    Math Biosci Eng; 2023 Jan; 20(2):2157-2182. PubMed ID: 36899527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development.
    Li YF; Hou QQ; Zhao S; Chen X; Tang M; Li L
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):623-637. PubMed ID: 36239794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.
    Huang X; Tang T; Zhang G; Liang T
    Mol Cancer; 2021 Mar; 20(1):50. PubMed ID: 33685460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.
    Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D
    Front Immunol; 2022; 13():773264. PubMed ID: 35185876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development.
    Ye L; Wang L; Yang J; Hu P; Zhang C; Tong S; Liu Z; Tian D
    J Transl Med; 2021 Aug; 19(1):352. PubMed ID: 34404444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development.
    Ma S; Ba Y; Ji H; Wang F; Du J; Hu S
    Front Immunol; 2021; 12():738435. PubMed ID: 34603319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analyses for the identification of tumor antigens and immune subtypes of gastric adenocarcinoma.
    Wei S; Sun Q; Chen J; Li X; Hu Z
    Front Genet; 2022; 13():1068112. PubMed ID: 36579327
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.
    Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY
    Front Genet; 2022; 13():853113. PubMed ID: 35734437
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development.
    Wu C; Qin C; Long W; Wang X; Xiao K; Liu Q
    J Big Data; 2022; 9(1):92. PubMed ID: 35855914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
    You W; Ouyang J; Cai Z; Chen Y; Wu X
    Front Immunol; 2022; 13():827506. PubMed ID: 35874675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma.
    Zhuang H; Tang C; Lin H; Zhang Z; Chen X; Wang W; Wang Q; Tan W; Yang L; Xie Z; Wang B; Chen B; Shang C; Chen Y
    Cell Oncol (Dordr); 2024 Aug; 47(4):1205-1220. PubMed ID: 38315287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma.
    Zhang S; Li S; Wei Y; Xiong Y; Liu Q; Hu Z; Zeng Z; Tang F; Ouyang Y
    Front Cell Dev Biol; 2022; 10():879278. PubMed ID: 35846349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype.
    Liu C; Papukashvili D; Dong Y; Wang X; Hu X; Yang N; Cai J; Xie F; Rcheulishvili N; Wang PG
    Front Cell Dev Biol; 2021; 9():783527. PubMed ID: 35127707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development.
    Fu J; Chen F; Lin Y; Gao J; Chen A; Yang J
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):4047-4061. PubMed ID: 36038676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological function and prognostic value of lymphoid-specific helicase in liver hepatocellular carcinoma.
    Fang Y; Tang W; Zhao D; Zhang X; Li N; Yang Y; Jin L; Li Z; Wei B; Miao Y; Zeng Z; Huang H
    Cancer Biomark; 2023; 38(2):225-239. PubMed ID: 37545225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.